Cited 0 times in
Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.